RSS
General Psychiatry
Research Update
Estrogen in Schizophrenia
Sarah Azarchi, MD. Dr. Azarchi has no financial relationships with companies related to this material.
Research Update
Overdiagnosis of ADHD
Alvin Marquez, MD. Dr. Marquez has no financial relationships with companies related to this material.
Research Update
Lithium, Valproate Have Low (and Similar) Risk of Kidney Injury
Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.
Research Update
Esketamine vs Quetiapine in Treatment-Resistant Depression
Ivy Song, MD. Dr. Song has no financial relationships with companies related to this material.
Expert Q&A
Antipsychotics Reconsidered
Harish Kavirajan, MD
Psychiatrist in private practice. Associate Professor of Clinical Psychiatry, University of California Irvine, Irvine, CA.
Dr. Kavirajan has no financial relationships with companies related to this material.
News of Note
Azstarys: Vyvanse’s Dexmethylphenidate Cousin
Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report.
Dr. Aiken has no financial relationships with companies related to this material.
Expert Q&A
How to Stop a Psychiatric Med
Mark Horowitz, MBBS, PhD
Research and Development Department, Goodmayes Hospital, North East London NHS Foundation Trust, Essex, UK; Visiting Lecturer in Psychopharmcology, King’s College London. Co-author of The Maudsley Deprescribing Guidelines (Wiley-Blackwell; 2024).
Dr. Horowitz is cofounder and consultant for Outro Health. Dr. Aiken has reviewed this educational activity and has determined that there is no commercial bias as a result of this financial relationship.
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
